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Introduction
Turner syndrome (TS) is a genetic disorder characterized by 
total or partial absence of one sex chromosome (1). It is one of 
the most common chromosomal disorder with an incidence of 
1:2500 female live births (2,3). The most prevalent karyotype is 
45,X, followed by mosaic patterns.
TS is associated with several morbidities that increase 
with age. Although TS causes several multisystem disorders, 
the most common presentation is usually due to short stature 
and primary gonadal deficiency. Patients may present with 
congenital malformations such as horseshoe kidney and 
coarctation of the aorta. They may also develop diabetes, 
hypothyroidism, hypertension, hearing loss, osteoporosis and 
bone fractures (4,5). Timely diagnosis and proper management 
of associated problems may reduce substantial morbidity and 
mortality and improve the quality of life in TS patients. Studies 
based on a large pediatric population which provide data on 
frequency of associated problems and their distribution among 
the different karyotypes are scarce (6,7,8).
In the present study, we aimed to define the frequency of 
associated problems in TS patients during childhood and the 
distribution of these clinical features according to karyotype 
and age by evaluating 842 patients with TS from 35 centers 
in Turkey.
Methods
Patients and Data Collection
In this study, we retrospectively evaluated the files of 842 
TS patients aged 0-18 years who were being followed in 35 
different centers from different regions of Turkey between 
September 2013 and February 2014. The study was approved 
by the Ethics Committee of Gülhane Military Medical Academy. 
All collected data were obtained from patient hospital records; 
no private information was included in the study.
A common case recording form (CRF) was created after 
literature review by four physicians (EY, FD, ES and PC) who 
were all experienced in TS and an expert on electronic CRF 
preparation (CA). The CRF covered demographic features, as 
well as clinical and laboratory findings of TS patients. The CRF 
was uploaded to the website of FAVOR Web Registry System 
(www.favorsci.org). Data entered in the registry were also 
checked for consistency by a research assistant (EY).
Physicians who were conducting an outpatient clinic for 
TS patients were asked to register their TS patients using the 
paper-based study forms. Another physician in each center 
was asked to register each patient online using the FAVOR 
Registry System. The time given for patient enrollment was 
four months and this time period ended on January 31, 2014, 
after which date the collected patient record data were entered 
to Microsoft Excel database and subsequently transferred to 
SPSS for Windows statistical software for statistical analysis.
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ABS TRACT
Objective: Turner syndrome (TS) is a chromosomal disorder caused by 
complete or partial X chromosome monosomy that manifests various clinical 
features depending on the karyotype and on the genetic background of 
affected girls. This study aimed to systematically investigate the key clinical 
features of TS in relationship to karyotype in a large pediatric Turkish patient 
population.
Methods: Our retrospective study included 842 karyotype-proven TS patients 
aged 0-18 years who were evaluated in 35 different centers in Turkey in the 
years 2013-2014.
Results: The most common karyotype was 45,X (50.7%), followed by 
45,X/46,XX (10.8%), 46,X,i(Xq) (10.1%) and 45,X/46,X,i(Xq) (9.5%). Mean age 
at diagnosis was 10.2±4.4 years. The most common presenting complaints 
were short stature and delayed puberty. Among patients diagnosed before 
age one year, the ratio of karyotype 45,X was significantly higher than that of 
other karyotype groups. Cardiac defects (bicuspid aortic valve, coarctation of 
the aorta and aortic stenosis) were the most common congenital anomalies, 
occurring in 25% of the TS cases. This was followed by urinary system 
anomalies (horseshoe kidney, double collector duct system and renal rotation) 
detected in 16.3%. Hashimoto’s thyroiditis was found in 11.1% of patients, 
gastrointestinal abnormalities in 8.9%, ear nose and throat problems in 
22.6%, dermatologic problems in 21.8% and osteoporosis in 15.3%. Learning 
difficulties and/or psychosocial problems were encountered in 39.1%. Insulin 
resistance and impaired fasting glucose were detected in 3.4% and 2.2%, 
respectively. Dyslipidemia prevalence was 11.4%.
Conclusion: This comprehensive study systematically evaluated the largest 
group of karyotype-proven TS girls to date. The karyotype distribution, 
congenital anomaly and comorbidity profile closely parallel that from other 
countries and support the need for close medical surveillance of these 
complex patients throughout their lifespan.
Key words: Nationwide study, Turner syndrome, children, diagnostic 
features, associated problems
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Clinical and Laboratory Evaluation
The karyotype and the presence of sex determinant 
region of Y (SRY) for all patients were questioned. A standard 
30-cell karyotype analysis from peripheral blood was made. 
Fluorescent in situ hybridization (FISH) was performed in case 
of strong suspicion of undetected mosaicism and 125/842 
patients were analyzed for SRY by FISH method. Some centers 
screened all patients for SRY, but SRY results were not available 
from all centers. Birth history and presenting characteristics 
(reason for admission, age of admission at presentation) were 
recorded. Findings on detailed questions relating to the cardiac, 
renal, gastrointestinal, endocrine systems, ear nose and throat, 
eye, skin and skeletal system, as well as psychosocial and 
metabolic problems that were relevant to TS were recorded 
by the physicians. Cardiac and renal findings were based on 
ultrasound examinations. Thyroid diseases were evaluated by 
testing for anti-thyroid peroxidase antibody, anti-thyroglobulin 
antibody, thyroid function tests and thyroid sonography.
Karyotypes of patients were classified according 
to numerical, structural and both numerical and structural 
abnormalities by a geneticist (DG). Patients with a body mass 
index (BMI) between 85-95 percent were defined as overweight 
and patients with a BMI over 95 percent as obese (9). Insulin 
resistance was assessed according to Turkish standards. 
Homeostasis model assessment of insulin resistance cut-off 
values in girls were calculated to be 2.22 in the pre-pubertal 
period and 3.82 in the pubertal period (10). Dyslipidemia was 
evaluated according to the recommendations of Integrated 
Guidelines for Cardiovascular Health and Risk Reduction in 
Children and Adolescents (11). A bone mineral density (BMD) 
Z-score less than -2.5 was defined as osteoporosis and a 
BMD Z-score between -1 and -2.5 as osteopenia (12). BMD 
was measured by dual-energy X-ray absorptiometry and was 
corrected for stature.
Statistical Analysis
Statistical analyses were performed using SPSS 
for Windows V. 22.0 statistical software. Frequencies and 
percentages represented the descriptive statistics for categorical 
variables and mean ± standard deviation values were used for 
continuous variables. Ratios were compared using chi-square 
test and mean values were compared using t-test. A p-value 
less than 0.05 was considered as statistically significant.
Results
A total of 842 patients with TS were registered. The 
distribution of patients according to karyotype analysis was 
as follows: 45,X (n=427; 50.7%), 45,X/46,XX (n=91; 10.8%), 
46,X,i(Xq) (n=85; 10.1%) and 45,X/46,X,i(Xq) (n=82, 9.5%) (Table 
1). The number of patients showing a mosaic pattern was 294 
(34.9%), 297 patients (35.3%) had X chromosome structural 
abnormalities and 167 patients (19.8%) had isochromosome 
X. Among the study cohort, the number of girls with a Y 
chromosome in karyotyping was 34 (4%).
SRY analysis was performed in 106 patients. Five of the 
patients (3 patients with 45,X karyotype, 1 with 46,Xi(Xq) and 
another with 45,X/46,X(Xp) were found to be positive for SRY 
among these 106 patients who were not detected to have a Y 
chromosome material by using standard methodology.
The mean gestational age, birth weight and height of the 
patients were 39±2 weeks, 3000±580 g and 48.0±2.5 cm, 
respectively. The mean age of presentation to clinics was 
10.2±4.4 years for the whole group. It was 10.1±4.8 years for 
patients with 45,X karyotype and 10.3±4.0 years for the rest of 
the karyotypes, p=0.391). Age at diagnosis was between the 
ages 1 and 12 years in 57.1% of the patients and older than 12 
years in 37.2%. A histogram according to age at diagnosis is 
given in Figure 1. About 5.7% of the patients were diagnosed 
before one year of age. Among patients diagnosed before 
age one year, the ratio of karyotype 45,X (n=29; 72.5%) was 
significantly higher than that of mosaic karyotype (n=6, 20%), 
structural (n=7; 17.5%) and isochromosome abnormalities 
(n=3; 7.5%). In patients diagnosed under 5 years of age, 66 out 
of 105 (62.9%) had 45,X karyotype.
The most frequent complaints at presentation were short 
stature in 708 (84.1%) patients, delayed puberty in 130 (15.4%) 
patients and edema in 37 (4.4%). Other presenting complaints 
in 128 (15.2%) patients were dysmorphism, congenital heart 
diseases and antenatal diagnosis. Mean ages of presentation 
for short stature and delayed puberty were 10.0±3.3 years and 
16.4±2.6 years, respectively.
The number of patients who were investigated for 
associated problems and frequencies of pathologies detected 
in the registered 842 TS patients are presented below.
Cardiovascular Pathologies
Cardiac evaluation was performed by transthoracic 
echocardiography in 719 patients. Cardiovascular pathologies 
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Figure 1. Histogram of age at diagnosis in children with Turner 
syndrome
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were detected in 180 (25%). Bicuspid aortic valve (n=61; 
8.6%), coarctation of the aorta (n=46; 6.5%) and aortic stenosis 
(n=38; 5.4%) were the most frequently detected abnormalities 
(Table 2). Seventeen patients had mitral insufficiency and 11 
had mitral valve prolapse. Ten patients had dilatation of the aorta 
and transthoracic echocardiography findings showed that 16 
patients had regurgitation of the aortic valve. Fifteen patients 
had hypertension. Forty-two cases presented with other cardiac 
abnormalities [atrial septal defect (14 cases), patent foramen 
ovale (6 cases), pulmonary stenosis (6 cases), ventricular 
septal defect (5 cases), partial anomalous pulmonary venous 
return (3 cases), others (8 cases)]. Cardiac malformations 
were more common in patients with 45,X karyotype (21.7%) 
compared to X mosaicism (13.6%), X chromosome structural 
abnormalities (9.9%) and isochromosome (9.3%). Coarctation 
of the aorta was more common in patients with 45,X karyotype 
(10.8%) compared to those with X chromosome structural 
abnormalities (2.1%), isochromosome (1.4%) and X mosaicism 
(1.2%).
Renal Pathologies
A total 117 out of 714 (16.3%) patients had renal anomalies 
detected on ultrasound screening. The most frequent ones 
were horseshoe kidney (9.0%) followed by double collector 
duct system (2.7%) and rotation anomalies (1.3%). Other 
encountered anomalies (renal agenesis, renal ectopia, etc) are 
listed in Table 2. We did not establish any difference between 
karyotypes with regard to renal anomalies.
Thyroid Pathologies
Findings indicative of Hashimoto’s or Graves diseases were 
evaluated in 792 patients by testing for anti-thyroid peroxidase 
antibody, anti-thyroglobulin antibody, free thyroxine (T4), thyroid 
stimulating hormone (TSH) and/or TSH receptor antibodies 
and/or thyroid sonography. 74 patients were found to have 
hypothyroidism and 14 patients subclinical hypothyroidism 
with high TSH but normal free T4 levels. Thyroid autoantibodies 
were positive in 82 out of 792 (10.4%) patients of which 42 
(51.2%) had hypothyroidism. 74% of the patients with positive 
thyroid autoantibody were older than 10 years, 24% of them 
were between 5-10 years and 2% were below 5 years of age. 
Only 3 patients had Graves disease. Thyroid autoimmunity was 
more common in patients with isochromosome karyotype 
(16.7%) and its frequency was significantly higher than that of 
other karyotype groups (9.2%) (p=0.008). No difference was 
observed among karyotypes with regard to hypothyroidism.
Gastrointestinal Pathologies
Gastrointestinal abnormalities were evaluated in 698 
patients by testing for liver function tests and celiac disease 
screening (testing for anti-transglutaminase, anti-gliadin 
and anti-endomysium antibodies). Endoscopy, gastroscopy, 
colonoscopy and biopsy were performed in suspected cases. 
Gastrointestinal abnormalities were detected in 62 patients 
(8.9%). Transaminases were elevated in 24 patients and 
9 patients had hepatosteatosis. Thirty-two patients were 
positive for celiac antibodies. The diagnosis of celiac disease 
had been confirmed by endoscopy in 18 patients. The most 
frequent karyotypes among 9 patients with hepatosteatosis 
was isochromosome X (p=0.008) and structural abnormalities 
(p=0.005).
Ear, Nose and Throat Problems
Evaluation for ear, nose and throat problems showed 
pathology in 122 out of 539 (22.6%) TS patients. Recurrent 
otitis media was the most common finding with 77 patients 
(14.3%), followed by hearing loss in 54 (10.0%) patients of 
whom 44 had conductive and 10 had sensory-neural type 
hearing loss. We did not find any correlation between recurrent 
otitis media and conductive hearing loss. Nineteen patients had 
undergone tympanostomia. Ear problem frequencies did not 
differ among various karyotypes.
Ophthalmologic Problems
Although we do not know the number of patients who 
had been evaluated, ophthalmologic problems were reported 
to be detected in 74 patients, most of which were strabismus 
encountered in 41, myopia in 16 and ptosis in 8 patients.
Dermatological Problems
Dermatological problems were detected in 159 out of 729 
(21.8%) patients. The most prevalent dermatologic problem 
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Table 1. Distribution of the Turner syndrome patients by karyotype 
(n=842)
Numeric (n=538) n (%)
Pure    45,X 427 (50.7)
Mosaic (n=111) 45,X/46,XX 91 (10.8)
45,X/47,XXX 13 (1.5)
45,X/46,XX/47,XXX 7 (0.8)
Structural (n=120)
Pure (n=117)    46,X,i(Xq) 85 (10.1)
46,X,del(Xp) 16 (1.9)
46,X,del(Xq) 11 (1.3)
46,X,r(X) 5 (0.6)
Mosaic (n=3) 46,XX/46,X,i(Xq) 2 (0.2)
46,XX/46,X,del(Xq) 1 (0.1)
Numeric/Structural (n=184)
45,X/46,X,i(Xq) 82 (9.5)
45,X/46,X,r(X) 29 (3.4)
45,X/46,XY 23 (2.7)
45,X/46,X,idic(Y) 11 (1.3)
45,X/46,X,+mar 10 (1.2)
Others 29 (3.4)
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Table 2. Distribution of pathologies in Turner syndrome patients by karyotype 
45,X (%) Mosaic (%) Structural (%) Isochromosome (%) Total (%)
Cardiovascular 
Bicuspid aortic valve 9.5 9.1 6.9 5.7 8.6
Coarctation of the aorta 10.8 1.2 2.1 1.4 6.5
Aortic stenosis 4.9 7.0 3.4 4.3 5.4
Aortic dilatation 2.2 0.8 0.4 0.0 1.4
Aortic regurgitation 1.1 2.1 0.9 0.7 1.3
Hypertension 2.2 2.9 1.7 1.4 2.1
Renal 
Horseshoe kidney 10.0 8.2 10.5 7.1 9.0
Rotational abnormalities 1.8 0.4 1.3 0.7 1.3
Ectopic kidney 0.3 1.2 0.8 1.4 0.7
Thyroid 
Hypothyroidism 9.8 12.4 14.7 14.6 11.1
Positive Anti-TPO 6.6 11.3 13.6 14.0 10.4
Positive Anti-TG 6.1 11.3 12.8 14.0 8.6
Goiter 0.5 1.5 1.2 1.3 0.9
Gastrointestinal 
Elevated liver enzymes 2.9 5.0 4.8 4.4 3.4
Hepatosteatosis 0.6 1.7 3.1 3.7 1.3
Ear and hearing
Recurrent middle ear infections 15.0 14.9 14.4 15.3 14.3
Conductive hearing loss 8.1 7.1 6.3 7.1 8.1
Sensorineural hearing loss 1.5 3.0 2.3 1.0 1.9
Tympanostomy 2.9 5.4 5.7 5.1 3.7
Orthopedic and skeletal 
Osteopenia-Osteoporosis 24.6 23.0 26.0 26.1 25.3
Congenital hip dislocation 0.9 1.3 0.7 1.1 1.1
Scoliosis 2.7 2.6 4.0 5.7 3.0
Dermatological 
Nevus 15.1 17.7 19.2 19.7 15.6
Psoriasis 1.1 1.2 1.3 1.5 1.2
Vitiligo 0.9 0.0 0.9 0.0 0.7
Keloid 1.1 0.0 0.4 0.8 0.7
Alopecia 0.9 0.0 0.4 0.8 0.6
Psychosocial 
Learning problems 16.2 15.2 18.7 12.5 16.1
Mental problems 12.2 10.1 17.4 14.3 13.7
Emotional problems 7.4 6.1 4.4 2.1 6.9
Metabolic 
Obesity 8.6 11.4 11.6 9.8 9.5
Overweight 6.3 5.3 4.9 6.9 5.5
Insulin resistance 3.2 2.8 4.5 4.9 3.4
Glucose intolerance 0.6 0.8 1.2 2.1 0.9
Anti-TPO: anti-thyroid peroxidase, Anti-TG: anti-thyroglobulin
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was presence of nevi, observed in 114 (15.6%) patients. 
Psoriasis, vitiligo, alopecia and keloid were other reported 
dermatological problems. A statistically significant increase 
was detected in the frequency of nevus by age (p=0.001). The 
frequency of nevi was 21.8% in patients older than 10 years, 
11.6% in those between 5-10 years and 4.8% in those under 
5 years of age. Frequency of dermatological problems did not 
vary among different karyotype groups.
Orthopedic and Metabolic Bone Problems
Orthopedic evaluation by an orthopedist and/or DEXA 
measurement was made in 442 patients and 122 (27.6%) 
were found to have at least one problem. Osteoporosis and 
osteopenia were the most common findings in 63 (15.3%) and 
49 (11.1%) patients, respectively. Scoliosis and hip dislocation 
were some other reported pathologies.
Psychosocial Problems
Two hundred and ninety-one patients were assessed for 
psychosocial problems by pediatric and adolescent psychiatrists 
and/or were reported to have undergone such an assessment 
in their school files. The most common problems were 
learning difficulty (16.1%) as well as vague mental (13.7%) and 
emotional (6.9%) problems (Table 2).
Metabolic Problems
Metabolic evaluation was done in 727 patients; 69 (9.5%) 
of these were obese and 40 (5.5%) were overweight. Insulin 
resistance (p=0.042) and glucose intolerance (p=0.003) were 
more common in patients with isochromosome X, but there 
was no association with obesity. Only 3 patients had type 2 
diabetes and 1 patient had type 1 diabetes. The metabolic 
test results of TS patients of normal weight and those of 
overweight or obese TS patients are presented in Table 3. 
Among 711 patients evaluated for dyslipidemia, 81 (11.4%) 
had the disease. The number of patients with high total 
cholesterol levels was 48 (6.8%), the number of patients 
with high triglyceride levels was 36 (5.1%) and the number of 
patients with high LDL levels was 27 (3.8%).
Discussion
In this study, we reviewed the presenting complaints, 
clinical characteristics, associated disorders and distribution of 
these according to karyotype analysis in 842 patients with TS 
from 35 centers in Turkey.
TS patients mostly present with X chromosome monosomy, 
followed by mosaic pattern. The most common forms of 
mosaicism are reported as 45,X/46,XX and 45,X/46,X,i(Xq) 
and the most commonly reported X chromosome structural 
abnormality is isochromosome Xq (1,2,3). In our population, 
the frequency of 45,X monosomy was 50.7% and that of 
mosaicism was 35.4%. The most frequent mosaic patterns 
were 45,X/46,XX (10.8%) and 45,X/46,X,i(Xq) (9.5%). Among 
structural abnormalities, pure isochromosome Xq structural 
abnormality was the most prevalent (10.1%). These findings 
are in agreement with the literature.
Identification of Y chromosome material in females with TS 
is important because of the risk of gonadoblastoma. Mosaicism 
for a cell line with a normal or abnormal Y chromosome is 
identified in 6% to 11% of patients with TS with standard 
cytogenetic techniques (13). Occult Y chromosome mosaicism 
detected by techniques other than standard cytogenetic in 
TS is variable in the different studies and also varies with the 
methodology used. In a meta-analysis of studies on a total 
of 541 patients with TS without Y chromosome material on 
routine cytogenetic analysis, frequency of mosaicism for a 
Y-containing cell line using molecular techniques (Southern 
blot and/or polymerase chain reaction) was reported to be 5%.
The percentage of patients with Y chromosome mosaicism 
(by molecular or standard cytogenetic techniques) was 8%; 
of these, 12% had gonadoblastoma. Detection of occult Y 
mosaicism in 45,X subjects using interphase FISH with a probe 
for the Y centromere (DYZ3) has been reported to range from 
0% to 4% (14,15). In our cohort, while 4% out of 842 cases 
were defined to have Y material using the standard method, 
5/106 (4.7%) of SRY negative patients by the standard method 
were found to be SRY positive using the FISH method.
The diagnosis of TS is usually delayed. In up to 10% of 
patients, diagnosis may be delayed until adulthood (1). In our 
study, the mean age at diagnosis was 10.2±4.4 years. The 
most common complaint at the first presentation is short 
stature and this is followed by a complaint of delay in puberty 
(2,4). In 70% of our cases, short stature was the presenting 
complaint and in line with the literature, the majority of our 
patients (86.3%) had short stature and/or delay in puberty. 
Patients with karyotype 45,X or isochromosome Xq were 
Table 3. Some metabolic problems in Turner syndrome patients 
according to weight status
Normal
weight
Over
weight
Obese p
Impaired fasting 
glucose (n, %)
6 (1.0) 3 (7.7) 7 (10.1) <0.001
Glucose intolerance 
(n, %)
4 (0.7) 1 (2.7) 1 (1.4) 0.396
Insulin resistance 
(n, %)
6 (1.0) 5 (12.5) 13 (18.8) <0.001
Elevated total 
cholesterol (n, %)
35 (6.0) 1 (2.7) 12 (18.2) 0.001
Elevated triglyceride 
(n, %)
20 (3.4) 4 (10.8) 12 (18.2) <0.001
Elevated  
LDL-cholesterol (n, %)
15 (2.6) 2 (5.4) 10 (15.2) <0.001
Decreased HDL-
cholesterol (n, %)
13 (2.2) 2 (5.4) 5 (7.6) 0.032
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diagnosed at an earlier age than those with other karyotypes. 
Frequency of diagnosis before age 5 years was 15.7% in 
patients with 45,X. This frequency was 9.0%, 9.1% and 9.7% 
in TS patients with mosaic, isochromosome and structural 
abnormalities, respectively.
TS is associated with a wide range of abnormalities 
affecting nearly every organ system. Congenital cardiovascular 
defects constitute the most important life-threatening 
pathology in these patients. It has been reported that the 50% 
of adult patients and 30% of pediatric patients with TS present 
with cardiovascular abnormalities (16,17). In our study, the 
frequency of cardiac abnormality in TS patients aged between 
0-18 years was 25%, a finding consistent with previous 
reports (18,19). A bicuspid aortic valve is reported as the most 
frequent congenital cardiac defect in TS (11-16%). A bicuspid 
aortic valve is reported in only 1-2% of the general population. 
It is usually an isolated abnormality. Next in frequency is 
coarctation of the aorta (7-11%) that is an important cause of 
hypertension and aortic stenosis/insufficiency (3-5%). Other 
cardiac pathologies include structural defects such as partial 
anomalous pulmonary venous connection, atrial and ventricular 
septal defects (18,19,20,21). In the present study, we found 
a smaller proportion of patients with bicuspid aortic valve 
(8.6%) compared to previous reports, but the frequencies of 
coarctation of the aorta (6.5%) and aortic stenosis (5.4%) were 
consistent with the literature.
In studies with large number of patients, it was also 
found that cardiac malformations were more prevalent among 
patients with 45,X than among patients with X mosaicism and 
X chromosome structural abnormalities. Similarly, coarctation 
of the aorta predominates in patients with the karyotype 
of 45,X (22,23,24,25,26,27). In our study also, cardiac 
malformations were significantly more common in patients 
with 45,X karyotype (21.7%) compared to other karyotypes 
(12.3%, p=0.001). Frequency of coarctation of the aorta was 
6.5% and most of these patients showed a 45,X karyotype 
(only 3 patients with coarctation of aorta had mosaicism). 
Some congenital cardiovascular anomalies may not have 
been detected using conventional imaging techniques. This 
is especially true for X mosaicism which includes 45X/46XX 
and 45X/46XdefectX. Because the former may have a milder 
phenotype, the latter are fully affected as all cells are missing 
the X (or Y) chromosome short arm (1,2). 
Hypertension has been reported in 7-17% of children 
and 24-40% of adults with TS (2,28,29,30,31). Possible 
mechanisms involved in the development of hypertension 
in this group of patients are abnormal vasculature, obesity, 
obstructive sleep apnea and metabolic syndrome. It has been 
stated that conventional blood pressure measurements may 
lead to underdiagnosis of hypertension in individuals with TS 
and ambulatory blood pressure monitoring is recommended. 
The frequency of hypertension in our study was 2.1%, a lower 
rate than in previous reports. This low frequency was thought 
to be due to a low rate of use of ambulatory blood pressure 
measurement method.
Renal pathologies have been reported to be of an 
approximate frequency of 30% in TS patients, a frequency 
which is nine times greater compared to the normal population 
(1,32,33,34). Common renal anomalies are horseshoe kidney, 
double collecting duct systems or rotational abnormalities each 
with a 5% to 10% frequency (2). In our study, renal abnormality 
rate was 16.3% and these were mostly horseshoe kidney 
(9.0%), double collecting duct systems (2.7%) and rotation 
problems (1.3%). Although there are different findings in the 
literature about karyotype and renal abnormalities (35), our 
findings did not demonstrate any karyotype differences with 
regard to renal abnormalities.
TS patients have an increased risk of thyroid diseases 
(thyroiditis, hypothyroidism, etc.) (4). In the present study, 
we found that 88 out of 792 (11.1%) TS patients suffered 
from hypothyroidism, either overt or subclinical. Antibody 
positivity was 10.7%. Radetti et al (36) studied 478 TS females 
with a mean age of 15.5 years and found that 22.2% had 
positive thyroid autoantibodies. Compensated hypothyroidism 
and hypothyroidism were present in 6.1% of these patients. 
In TS patients, thyroid dysfunction and autoimmunity increase 
with age (37). A study investigating TS patients younger than 
30 years reported that thyroid autoantibody was positive in 
16.7% of patients between 0-9.9 years, 47.7% between 
10-19.9 years and 37.5% between 20-29.9 years of age (38). 
In our study also, a striking increase was observed in the 
frequency of thyroid autoantibody positivity by age; 74% of 
the patients with positive thyroid autoantibodies were over 
10 years, 24% of them were between 5-9.99 years and 
2% were younger than 5 years. We observed that antibody 
positivity significantly increased with age. Autoimmune thyroid 
disease has been found to be mostly prevalent in women 
with the isochromosome [46,Xi(Xq)] karyotype than other 
karyotypes (39,40). Similarly, in our study, a positive thyroid 
autoantibody was found to be more prevalent among patients 
with isochromosome X compared to other groups (p=0.008). 
No difference was observed among karyotypes regarding 
hypothyroidism.
Elevated liver enzymes and increased risk of cirrhosis have 
been reported in patients with TS (41). Improvement in liver 
functions after estrogen replacement suggested the role of 
estrogen deficiency (42). In the present study, 62 out of 698 
patients (8.9%) had gastrointestinal pathologies. Transaminases 
were elevated in 24 (3.4%) patients, of whom 5 were younger 
than 10 years of age. Nine (1.3%) patients had hepatosteatosis 
and 4 of these patients were non-obese.
Patients with TS have a 2-10 fold increased risk of 
developing inflammatory bowel disease (3%) and a 11-fold 
increased risk of developing (2.2-8.1%) celiac disease as 
compared to the normal population (2,29,43,44). Inflammatory 
bowel disease was not detected in this present study. Biopsy-
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proven celiac disease was detected in 18 (2.5%) and celiac 
antibody positivity in 32 (4.5%) patients. Prevalence of celiac 
disease in our cohort was higher than in healthy Turkish school 
children which have a reported prevalence of 0.47% (45). No 
karyotypic characteristics were observed in the 6 of the 18 
celiac patients investigated.
Craniofacial malformations that cause Eustachian tubes 
dysfunction may result in recurrent otitis media and consequent 
hearing problems in children with TS. Hearing problems may 
be seen up to 30% in childhood and up to 90% in adulthood 
in patients with TS (46,47). Conductive type hearing loss is 
mostly prevalent in early ages, while sensorineural hearing 
loss generally develops in late childhood or early adulthood 
and shows an increase with age (7,48,49). In our cohort, 122 
(22.6%) patients had ear, nose and throat problems. Recurrent 
otitis media was the most common finding and existed in 77 
patients. Hearing loss was detected in 54 patients; 44 of these 
had conductive type and 10 sensorineural type hearing loss. 
Hearing loss was more prevalent among patients older than 
5 years. Hearing problems are reported to be least prevalent 
in TS patients with mosaicism and more severe in patients 
with 45,X monosomy, isochromosome X and with loss of the 
p-arm of the X chromosome (50). However, in our study, ear 
problems did not differ among karyotypes. The low frequency 
of hearing problems detected in our study could be due to lack 
of sufficient awareness and underdiagnosis.
Ophthalmologic anomalies can be observed in about 63% 
of patients with TS (1). Strabismus, ptosis, amblyopia and 
color blindness are seen in decreasing order. In one review, 
strabismus was found to be as frequent as 33% and ptosis 
as 16% (51). Some studies reported that myopia can be 
associated with TS (2,7,51). Among our cohort, 74 patients 
were detected to have ocular problems at presentation. The 
most common pathology was strabismus (n=41), followed 
by myopia (n=16) and ptosis (n=8). We cannot make any 
comment on the prevalence of these disorders as there was no 
information in the records for the rest of the patients.
Females with TS are prone to some skin pathologies 
such as pigmented nevi, psoriasis, alopecia areata and keloid 
formation after surgical interventions (52). Pigmented nevi 
were reported to be present in 27% of patients regardless of 
the karyotype and to show an increase with growth hormone 
replacement (53,54). The frequency of these dermatological 
problems in our study was 21.8%. Presence of nevi was the 
most common one followed by psoriasis, vitiligo, alopecia, 
keloid and other skin problems. Since the frequency of nevi 
may show an increase with age, TS patients should be 
monitored for this manifestation.
Orthopedic evaluation in TS patients is of importance 
starting from infancy as they may have a high risk of congenital 
hip dislocation. In adolescence, the risk for developing scoliosis 
is as high as 10% (55,56). In our study, the frequency of 
scoliosis was 3%. Scoliosis was more prevalent in children 
older than 10 years compared to those aged 5-10 years and 
was not seen in patients younger than 5 years.
Estrogen deficiency in patients with TS increases the risk 
of osteoporosis. Bone mass reduction has been reported in 
25% of women with TS (1). Osteoporosis and osteopenia 
were present in 63 (15.3%) and 49 (11.1%) of our patients, 
respectively and increased with age (p=0.001). The relatively 
low rate of osteoporosis/osteopenia in our series compared to 
the literature was attributed to the younger age of our patients. 
Karyotypes of patients with osteoporosis, osteopenia or other 
orthopedic/skeletal problems did not show any differences of 
statistical significance.
TS patients generally have normal intelligence except for 
mosaic karyotype with ring X chromosome. However, they 
have impaired non-verbal skills and low arithmetic skills. In our 
study, 291 patients were assessed for psychosocial problems 
and 39.1% were found to have psychosocial problems. 
Learning difficulties at school, as well as mental and emotional 
disorders (diagnosed by pediatric psychiatrists) were the most 
commonly encountered problems. These findings could be 
related to increased awareness of these problems as well as 
to inadequate adjustment to social environment. Only 11 out 
of 36 patients with ring chromosomes had been evaluated for 
psychological disorders, but there appeared to be no difference 
between patients with ring chromosomes and patients with 
other karyotypes regarding mental problems. As expected, 
emotional and learning problems increased with age (p=0.02), 
while no age difference was seen regarding mental disorders.
TS girls exhibit more metabolic risk factors and reduced 
beta cell function compared to age- and BMI-standard 
deviation score-matched girls (57). Waist circumference and 
subcutaneous adipose tissue measurements were higher in 
girls with TS compared to an age-matched healthy adolescent 
control group with a BMI of +1 standard deviation (58). In our 
study, 124 (17%) patients had metabolic problems. Among 
these patients, 69 were obese (9.5%) and 40 were overweight 
(5.5%). However, these figures are not high since, according 
to the Turkish Ministry of Health reports for 2010-2014, the 
prevalence of obesity in Turkish girls between 3-17 ages is 
14.7 %. 
Type 2 diabetes mellitus is reported to be more common 
in TS. Impaired glucose tolerance is seen at early ages and 
although obesity is a common problem in these patients, is 
not associated with either karyotype or BMI (58,59,60,61). 
A total of 122 patients were evaluated for any disorders of 
glucose metabolism. The results demonstrated that 24 patients 
(19.6%) had insulin resistance (5 of these patients had normal 
BMI), 16 patients (13.1%) had impaired fasting glucose (6 of 
these patients had normal BMI), 6 patients (4.9%) had glucose 
intolerance and 3 patients had type 2 diabetes. Of the 3 type 
2 diabetes patients, 2 were obese and one had a normal BMI. 
Their ages were 11, 16 and 18 years. It has been emphasized 
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that haploinsufficiency for unknown Xp genes increases the 
risk for diabetes mellitus and that an excess dosage of Xq 
genes compounds the risk (62). In our study, insulin resistance 
and glucose intolerance were more common in patients 
with isochromosome Xq. In the majority of these cases, the 
abnormalities in glucose metabolism were related to obesity.
The present study provides data on the demographic 
characteristics and frequency of associated problems in 
TS during childhood, based on the experience of Pediatric 
Endocrinology centers in Turkey. The findings indicate that 
some of the related problems are not being thoroughly 
searched in all patients. In those with complete evaluation, 
frequency of associated problems and their relationship with 
the karyotype groups are similar to that reported for other 
populations.
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